Cilostazol for Prevention of Recurrent Stroke Trial
Status:
NOT_YET_RECRUITING
Trial end date:
2031-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn whether adding cilostazol to aspirin or clopidogrel prevents stroke and heart attack in people who have had a stroke or mini-stroke.
Phase:
PHASE3
Details
Lead Sponsor:
Stanford University
Collaborators:
Medical University of South Carolina National Institute of Neurological Disorders and Stroke (NINDS) University of Cincinnati Yale University